VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Patient aged 18 years or older                     │ Patient aged 18 years or older                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient suffering from mild to moderate active     │ Patient suffering from mild to moderate active     │     100 │
│ proctitis or distal proctosigmoiditis (MAYO score  │ proctitis or distal proctosigmoiditis (MAYO score  │         │
│ ≥ 3 and ≤ 10) at inclusion based on clinical and   │ ≥ 3 and ≤ 10) at inclusion based on clinical and   │         │
│ endoscopic findings within 6 months before study   │ endoscopic findings within 6 months before study   │         │
│ inclusion                                          │ inclusion                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient with evidence of endoscopic active         │ Patient with evidence of endoscopic active         │     100 │
│ proctitis or distal proctosigmoiditis (Montreal    │ proctitis or distal proctosigmoiditis (Montreal    │         │
│ classification E1 or E2 defined by an involvement  │ classification E1 or E2 defined by an involvement  │         │
│ not exceeding 25 cm from the anal margin) within 6 │ not exceeding 25 cm from the anal margin) within 6 │         │
│ months before study inclusion                      │ months before study inclusion                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Treatment of the current flare with Pentasa® to    │ Treatment of the current flare with Pentasa® to    │     100 │
│ induce a remission initiated by the patient, the   │ induce a remission initiated by the patient, the   │         │
│ general practitioner or the gastroenterologist,    │ general practitioner or the gastroenterologist,    │         │
│ during the inclusion visit or during the week      │ during the inclusion visit or during the week      │         │
│ before the inclusion visit                         │ before the inclusion visit                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient having received oral and written           │ Patient having received oral and written           │     100 │
│ information on the study, without any objections   │ information on the study, without any objections   │         │
│ for the use of his/her personal data, and having   │ for the use of his/her personal data, and having   │         │
│ signed a written Informed Consent Form             │ signed a written Informed Consent Form             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient included in an interventional study        │ Patient included in an interventional study        │     100 │
│ assessing treatment for active proctitis or distal │ assessing treatment for active proctitis or distal │         │
│ proctosigmoiditis                                  │ proctosigmoiditis                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient with left sided, colitis or pancolitis     │ Patient with left sided, colitis or pancolitis     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient with severe proctitis (MAYO score ≥ 11 at  │ Patient with severe proctitis (MAYO score ≥ 11 at  │     100 │
│ inclusion)                                         │ inclusion)                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient previously treated with biologics          │ Patient previously treated with biologics          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient treated with immunosuppressive within 1    │ Patient treated with immunosuppressive within 1    │     100 │
│ month before study inclusion                       │ month before study inclusion                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patient treated with corticosteroids within 2      │ Patient treated with corticosteroids within 2      │     100 │
│ weeks before study inclusion                       │ weeks before study inclusion                       │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                  │   Score │
╞═══════════════════════════════════╪════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Patient aged 18 years or older │      48 │
╘═══════════════════════════════════╧════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 99
Average Levenshtein Ratio of individual lines: 95.66666666666667
OverAll Ratio: 97.33333333333334
